Should Three People be Allowed to Make a Baby?
By Arielle Duhaime-Ross,
Verge
| 06. 12. 2014
Untitled Document
For more than a decade, scientists have been developing a fertility technique that involves combining DNA from three parents to make a child. The technique, which has yet to be tested on humans, aims to help women who suffer from mitochondrial disease conceive a baby to which they are genetically related. But as the science inches closer to the human trial stage — some say that might happen in as little as two years — the scientific debate surrounding "three-parent babies" grows louder, and more polarized.
Just last week, for instance, a British scientific panel decided that the fertility technique is "not unsafe" for patients who suffer from mitochondrial disease. The decision hints that British government may soon amend legislation that currently bars the procedure, called mitochondrial replacement (MR), from entering human trials. Yet an American scientific panel reached a different conclusion in February when it decided that the science supporting MR was inconclusive and lacking. Thus, the first baby with three genetic parents will likely be British, and the two countries that are seriously considering...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...